That's our claim. Below, we put it to the test — comparing DWU against five alternatives you're probably weighing, including the ones that might be better for you than we are.
We sell a macro research subscription. You know that, so we won't pretend otherwise. What we can do is give you both sides of the coin on every option — including ours — so you can decide with full information.
We say David Woo Unbound gives you institutional-level macro research at a retail price. That's a big claim, and you'd be right to test it. If you're considering a subscription, you've probably also thought about the alternatives — free content, retail platforms, maybe even institutional desks.
Below, we compare DWU against five paths you might take. For each, we show where the alternative genuinely wins, where our institutional experience creates a real difference, and — critically — where we fall short. Because the only way "institutional research at retail cost" means anything is if we're honest about what it does and doesn't include.
YouTube, X/Twitter, Substack, podcasts — there's more free macro commentary available today than at any point in history. Some of it is excellent. The question isn't whether free content exists — it's whether free content can deliver the institutional rigor, accountability, and structure that separates commentary from research.
Free content gives you breadth we can't match. We're two people with a specific macro framework. If our lens is wrong for a given period, you'll feel it more than someone sampling 15 free voices. We also can't compete with the real-time speed of X/Twitter for breaking market news — our daily brief publishes before market open, not in the moment.
Investors still exploring whether macro analysis matters to their approach, people who enjoy assembling a mosaic of perspectives, and anyone who's more interested in market commentary as intellectual entertainment than as a system for generating actionable trade ideas.
Seeking Alpha, Motley Fool, Morningstar, and similar platforms serve millions of retail investors. They offer enormous breadth of bottom-up stock coverage — something we don't try to replicate. The real question is whether their crowdsourced, fundamentals-first approach gives you the same macro lens you'd get from an institutional research desk. In several ways, their approach is genuinely better than ours.
If you want deep fundamental analysis of individual companies — earnings models, DCF valuations, management quality assessments — retail platforms will serve you far better than we will. We don't cover earnings calls. We don't maintain financial models on hundreds of stocks. Our stock picks are driven by macro positioning, not company-specific research. If the macro environment is calm and stock-picking is driven by company fundamentals, our edge narrows considerably.
Investors who want to research individual companies in depth, people who value quantitative screening tools, buy-and-hold investors building long-term positions based on company fundamentals, and anyone who wants coverage across thousands of tickers rather than a focused macro portfolio.
Goldman Sachs, J.P. Morgan, Morgan Stanley, BCA Research — this is the world David and John came from. David ran global rates strategy at one of the largest banks in the world. John spent two decades telling the smartest hedge funds in the world what to trade. When we say "institutional research at retail cost," this is the benchmark we're measured against. The honest answer: institutional desks still beat us in important ways. Here's where, and where the gap is smaller than the price difference suggests.
Let's be direct: if you can afford institutional research and need the full multi-asset-class coverage it provides, it is better than what we offer. We are two people. Institutional desks are armies. We don't cover currencies, commodities, or fixed income with the same rigor. We can't provide bespoke analysis tailored to your specific portfolio. And we don't have the proprietary data feeds that institutional clients receive. Our advantage is that we make institutional-quality macro thinking accessible at a fraction of the cost — but we'd never claim we replace the full institutional research experience.
Professional fund managers and institutional allocators managing large portfolios across multiple asset classes, who need bespoke coverage and direct analyst access, and for whom $25,000+/year in research fees is a rounding error on their management fee revenue.
Many of our subscribers are smart, self-directed investors who read the Fed minutes, follow FRED data, and build their own macro views. We respect that deeply. The question is whether institutional-level pattern recognition — the kind built over 30+ years inside the largest banks in the world — is worth $100/year to supplement your own process.
Subscribing to anyone's research creates a subtle dependency that can atrophy your own analytical muscles. If you follow our trade ideas mechanically without understanding the macro thesis behind them, you'll be lost the moment our framework doesn't apply. We also can't know your personal risk tolerance, time horizon, or full financial picture. The best investors we've seen treat external research as one input — not a replacement for their own judgment.
Investors who enjoy the research process itself, people with the time to commit 10–20 hours/week to macro analysis, experienced traders who've already built a framework and want to refine it through primary source work, and anyone who is philosophically committed to fully owning their investment decisions without external influence.
This is the comparison most macro services won't make — but it's the one that matters most. The data is unambiguous: most active strategies underperform passive indexing over long time horizons. So why would you pay for institutional-grade macro research at all, at any price? We owe you an honest answer.
We'll say what most research services won't: if your time horizon is 20+ years, you don't enjoy following markets, and you have the discipline to never sell during a crash, passive indexing is likely to outperform any active macro strategy — including ours. Our target is to beat the S&P by 5% annually, and even if we achieve it, there will be years where we underperform. Meanwhile, passive investing requires zero effort, zero subscription cost, and zero emotional energy. For many people, that's not just good enough — it's optimal.
Long-term investors with 20+ year horizons who don't want to actively manage their money, people who value simplicity and time freedom above potential incremental returns, and anyone without a strong interest in understanding macro dynamics. It's an excellent default strategy, and no honest research provider should tell you otherwise.
| Option | Annual Cost | Biggest Strength | Biggest Weakness | Best If You… |
|---|---|---|---|---|
| Free Content | $0 | Diversity of voices, zero commitment | No accountability, no coherent narrative | Are still exploring macro |
| Retail Platforms | $120–$500 | Bottom-up company research at scale | Crowdsourced quality, no skin in game | Want individual stock analysis |
| Institutional Desks | $10K–$50K+ | Full multi-asset global coverage | Cost; conflicts of interest | Manage institutional capital |
| DIY Research | $0 (+ your time) | Deep learning, full customization | 10–20 hrs/week; hard to build pattern recognition | Love the research process |
| Passive Indexing | ~$0 | Beats most active strategies over 20 years | No understanding; invisible opportunity cost | Want zero effort, long horizon |
| David Woo Unbound | $100–$150 | Institutional macro at retail cost, skin in game, daily accountability | Two people; narrow focus; may underperform in calm markets | Want institutional edge without institutional fees |
You've seen where we win and where we fall short. If you want to test the claim for yourself, the free trial costs nothing and comes with no commitment. If one of the alternatives above is a better fit — genuinely, we'd rather you find the right one.
30-day free trial · Cancel anytime
